Navigation Links
Aspen Institute to Release Presidential Candidates' Responses to Health Care Reform Questionnaire; New Zogby Poll Findings Also to be Released
Date:5/8/2008

WASHINGTON, May 8 /PRNewswire-USNewswire/ -- On Wednesday, May 14th, the Aspen Institute Health Stewardship Project will release the responses from the presidential candidates, John McCain, Barack Obama, and Hillary Rodham Clinton, to a questionnaire on health care reform. The project's director and co-chairs will provide analysis of the candidates' responses and discuss the findings of a related, newly commissioned poll by Zogby International.

The co-chairs will comment on where the candidates hit the mark and where they fall short. Representatives from the campaigns also have been invited to speak. Briefing details are as follows:

WHO: Michelle McMurry, MD, PhD

Director, Aspen Institute Health Stewardship Project

Christine Todd Whitman,

Former governor of New Jersey; Founder, Whitman Strategy Group

Mark Ganz

President and CEO, Regence BlueCross BlueShield

Robert Honigberg, MD, MBA

Chief Medical Officer, GE Healthcare

Elizabeth Teisberg, PhD

Author and Associate Professor, University of Virginia Darden School of Business

WHEN: Wednesday, May 14, at Noon

WHERE: U.S. Senate Russell Office Building, Room 385

RSVP: Please contact Noah Bartolucci at noah.bartolucci@aspeninstitute.org.

* Lunch will be provided.

BACKGROUND: Launched in October 2007, the Aspen Health Stewardship Project is a bipartisan initiative tasked with reframing and broadening the national dialogue on health care reform leading up to the 2008 presidential election and beyond. The project co-chairs are Whitman, Ganz, Teisberg and Joe Hogan, president and CEO of GE Healthcare. The project also features an advisory board of top physicians, scholars, health policy experts and information technology leaders. For more information, visit http://www.AspenHealthStewardship.com.


'/>"/>
SOURCE The Aspen Institute
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Aspen Health Stewardship Project Provides Means for Presidential Candidates to Reframe Health Care Reform
2. AspenBio Outlines Steps for FDA 510(k) Clearance of AppyScore(TM), the First Blood-Based Screen/Triage Test for Human Appendicitis
3. Health Care Corporate Compliance Certificate Program to Be Offered at Hamline University School of Laws Health Law Institute
4. The Lucian Leape Institute at the National Patient Safety Foundation Announces the Appointment of Two New Members
5. NBCHs Community Coalitions Health Institute Receives CDC Grant
6. Integrated Benefits Institute Releases Research on True Cost of Absence for Employers
7. Improving Access to Safe Water, Sanitation, Hygiene Requires Better Decision-Making Tools, Finds Joint Wilson Center-Pacific Institute Report
8. Canary Foundation and the National Cancer Institute Launch New Prostate Cancer Study
9. Prominent Advocate on HIV/AIDS Issues Joins Altarum Institute
10. Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications
11. OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2013)... Grand Rapids, Michigan (PRWEB) December 10, 2013 ... high gear this month with a focus on African American ... killed by breast cancer in the United States in 2013, ... Alive aims to motivate Michigan residents to take a stand ... platform for survivors to share and encourage others along the ...
(Date:12/10/2013)... 2013 SmartDraw Software celebrates its 20th anniversary ... the technology world, it’s eons. , Consider all of the ... 1994. We had no iPods—MP3s didn’t even exist. There were ... rented VHS tapes. Almost no one had heard of the ... Facebook and Twitter were light years away. , But there ...
(Date:12/10/2013)... Manitoba (PRWEB) December 10, 2013 America the ... developed nations, according to a recent survey that was ... which was published in Health Affairs in November, drug prices ... million Americans, 21 percent, are skipping their medication because of ... percent. These numbers are especially concerning when you compare them ...
(Date:12/10/2013)... The most effective, proven selling tips are now easy to ... All Time by John Westman. This book is designed ... In just 2 minutes, one of these tips can be ... each tip. More powerful questions and messages can be created ... would like to start selling and persuading more effectively. , ...
(Date:12/10/2013)... Charlestown, Rhode Island (PRWEB) December 10, 2013 ... Royal Flush Havanese knows that most of its readers, ... of certain pet treats from China. Nevertheless, such are the ... Flush Havanese feels it cannot hurt to give the warning ... have been a great many reports of canine fatalities due ...
Breaking Medicine News(10 mins):Health News:Local Campaign to Educate African American Women on Increased Risk of Breast Cancer 2Health News:SmartDraw Software Celebrates 20 Years of Success 2Health News:Access and Affordability to Drugs and Healthcare Worst in the U.S. Compared to 10 Other Countries 2Health News:Marketing Expert Philip Kotler Praises New Book: Top Ten Selling Tips of All Time 2Health News:Keeping Dogs Safe From Tainted Treats From China 2Health News:Keeping Dogs Safe From Tainted Treats From China 3
... transfused blood is more than 28 days old, study finds , ... and are given a major transfusion of red blood cells that ... likely to die as those who receive fresher red blood cells, ... trauma patients who were treated with five or more units of ...
... no sure-fire test exists, experts say, , FRIDAY, Oct. 2 ... is made, the earlier treatment can begin. On that, experts ... to predict your odds of developing the degenerative brain disorder ... easier than ever to figure it out: Do you or ...
... GLEN BURNIE, Md., Oct. 2 APWU Health Plan is ... Our exceptionally rated High Option sees a four percent increase ... a zero percent increase. APWU Health Plan is offering ... year we are adding new benefits and enhancing old ones. ...
... (Nasdaq: FOLD ) today announced preliminary results from ... safety, tolerability and preliminary efficacy of its investigational drug, ... 1 Gaucher disease. Two dose regimens of Plicera ... days on/seven days off) were studied during this six ...
... these patients when oral hygiene is neglected, study finds , ... at increased risk for heart problems caused by accumulation of ... of Dentistry researchers studied 128 black and white women and ... cause a change in total white blood cell count, a ...
... the last decade. Today, one can talk, text message, shoot photos ... Now imagine a cell phone that can be used to monitor ... a major disaster like a hurricane or earthquake. ... Samueli School of Engineering and Applied Science, has been working to ...
Cached Medicine News:Health News:Fresh Blood Boosts Survival in Trauma Patients 2Health News:Uncertainty Surrounds Testing for Alzheimer's 2Health News:Uncertainty Surrounds Testing for Alzheimer's 3Health News:Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease 2Health News:Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease 3Health News:Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease 4Health News:Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease 5Health News:Dental Plaque Buildup May Raise Heart Risk in Black Men 2Health News:NIH recognizes engineering professor's innovative research with major award 2Health News:NIH recognizes engineering professor's innovative research with major award 3
(Date:12/10/2013)... Massachusetts , December 10, 2013 ... journal, Food and Chemical Toxicology , alongside a ... to retract the paper by Séralini et al.(Séralini et ... published an article titled "Long term toxicity of a ... Séralini et al .(Séralini et al., 2012).  The ...
(Date:12/10/2013)... 2013 Based on its recent research ... Sullivan presents Microlife Corporation (Microlife) with the 2013 ... Innovation & Leadership. Microlife has strategically invested in ... large patient base for the diagnosis of atrial ... an automated oscillometric blood pressure monitor equipped with ...
(Date:12/9/2013)... -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: ... investigator-initiated Phase 2 clinical trial of tosedostat in ... older patients with acute myeloid leukemia (AML) or ... selective inhibitor of aminopeptidases, which are required by ... growth and tumor cell survival. Tosedostat is administered ...
Breaking Medicine Technology:Food and Chemical Toxicology Editor-in-Chief, A. Wallace Hayes, Publishes Response to Letters to the Editors 2Food and Chemical Toxicology Editor-in-Chief, A. Wallace Hayes, Publishes Response to Letters to the Editors 3Food and Chemical Toxicology Editor-in-Chief, A. Wallace Hayes, Publishes Response to Letters to the Editors 4Food and Chemical Toxicology Editor-in-Chief, A. Wallace Hayes, Publishes Response to Letters to the Editors 5Food and Chemical Toxicology Editor-in-Chief, A. Wallace Hayes, Publishes Response to Letters to the Editors 6Microlife Wins Accolades from Frost & Sullivan for its Unique Automated Oscillometric Blood Pressure Monitor 2Microlife Wins Accolades from Frost & Sullivan for its Unique Automated Oscillometric Blood Pressure Monitor 3Microlife Wins Accolades from Frost & Sullivan for its Unique Automated Oscillometric Blood Pressure Monitor 4Cell Therapeutics Announces Presentation of Interim Results from Phase 2 Tosedostat Trial in Older Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) at ASH Annual Meeting 2Cell Therapeutics Announces Presentation of Interim Results from Phase 2 Tosedostat Trial in Older Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) at ASH Annual Meeting 3Cell Therapeutics Announces Presentation of Interim Results from Phase 2 Tosedostat Trial in Older Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) at ASH Annual Meeting 4Cell Therapeutics Announces Presentation of Interim Results from Phase 2 Tosedostat Trial in Older Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) at ASH Annual Meeting 5
... Nov. 16, 2011 ZONARE Medical Systems today ... & Sullivan 2011 North American Technology Innovation Award ... the development of Zone Sonography Technology (ZST), the ... one of the industry,s most significant ultrasound breakthroughs. ...
... Nov. 16, 2011 Hotspur Technologies today announced ... Catheter in the United States and select international ... Hotspur,s innovative GPSCath™ Balloon Dilatation Catheter integrates ... physicians to inject contrast during a procedure without ...
Cached Medicine Technology:Frost & Sullivan Honors ZONARE for Ultrasound Innovation 2Hotspur Technologies Commences US Launch at Veith/AIM Conference in New York City 2
Prevail is a fast-acting, effective antimicrobial gel that makes preoperative preps easier. This unique gel formulation comes in a specifically designed, easy to use applicator for excellent flow con...
The new, single-use 26 mL applicator is latex-free, hands-off and sterile to help prevent cross-contamination. The applicator is designed for a smooth delivery of the solution for larger surgical pro...
These simple but effective single-dose, hands-off, ampulized applicators have revolutionized skin preparation in hospitals....
... Panel consists of plasma specimens with reactivity ... antibodies to the Hepatitis C Virus. ,This ... and diagnostic laboratories to evaluate their anti-HCV ... systems are included for comparative analysis on ...
Medicine Products: